NL7712100A - Farmaceutische preparaten. - Google Patents

Farmaceutische preparaten.

Info

Publication number
NL7712100A
NL7712100A NL7712100A NL7712100A NL7712100A NL 7712100 A NL7712100 A NL 7712100A NL 7712100 A NL7712100 A NL 7712100A NL 7712100 A NL7712100 A NL 7712100A NL 7712100 A NL7712100 A NL 7712100A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NL7712100A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NL7712100A publication Critical patent/NL7712100A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7712100A 1976-11-08 1977-11-02 Farmaceutische preparaten. NL7712100A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (nl) 1976-11-08 1976-11-08

Publications (1)

Publication Number Publication Date
NL7712100A true NL7712100A (nl) 1978-05-10

Family

ID=19728406

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7712100A NL7712100A (nl) 1976-11-08 1977-11-02 Farmaceutische preparaten.

Country Status (9)

Country Link
JP (1) JPS5359035A (nl)
AU (1) AU3041877A (nl)
BE (1) BE860526A (nl)
DE (1) DE2749318A1 (nl)
FR (1) FR2369841A1 (nl)
IL (1) IL53318A0 (nl)
LU (1) LU76150A1 (nl)
NL (1) NL7712100A (nl)
ZA (1) ZA776645B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (de) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate

Also Published As

Publication number Publication date
IL53318A0 (en) 1978-01-31
ZA776645B (en) 1978-08-30
BE860526A (fr) 1978-05-08
LU76150A1 (nl) 1978-07-10
JPS5359035A (en) 1978-05-27
AU3041877A (en) 1979-05-17
DE2749318A1 (de) 1978-05-11
FR2369841A1 (fr) 1978-06-02

Similar Documents

Publication Publication Date Title
NO801863L (no) Farmasoeytiske preparater.
NL7705259A (nl) Herbicide preparaten.
NL7508437A (nl) Vitaminepreparaten.
NL7704980A (nl) Injectiespuit.
NL7500552A (nl) Farmaceutische preparaten.
NL170258C (nl) Capsule.
NL7613107A (nl) Fungicide preparaten.
NO144444C (no) Fortillegg for droevtyggere.
NL7801421A (nl) Preparaten.
NL7806573A (nl) Preparaten met geneeskundige werkzaamheid.
NO770663L (no) Kosmetiske preparater.
DK280077A (da) Vitaminpreparat
NL7708024A (nl) Gefixeerde haptoglobine-preparaten.
FI763506A (fi) Farmaceutisk naeringsfoerpackning
NL7801921A (nl) Farmaceutische preparaten.
FI773812A (fi) Farmaceutiska foereningar
NL7608376A (nl) Thermoplastische vormpreparaten.
NL7510946A (nl) Herbicide-preparaten.
NL7704084A (nl) Medicinale preparaten.
FI773813A (fi) Farmaceutiska foereningar
NL7702025A (nl) Capsule.
NO811003L (no) Farmasoeytiske preparater.
NO770586L (no) Herbicide preparater.
NL7607939A (nl) Anthelmintische preparaten.
NL7705560A (nl) Farmaceutisch preparaat.

Legal Events

Date Code Title Description
BV The patent application has lapsed